IDO1 and Huntington disease: IDO is upregulated by microglial activation [25,26].and pathway activity is thought to contribute to HD progression via generation of increased amounts of neurotoxic intermediates 3-hydroxykynurenine (3-HK) and quinolinic acid [23,24,27–29].